Compliance with the document of the spanish society of nephrology 2002 document for the control of diabetic nephropathy in catalonia (ECCODIAB)

Keyphrases

• Catalonia 100%
• Spanish Society 100%
• Diabetic Nephropathy 100%
• Nephrology 100%
• Hemoglobin A1c (HbA1c) 100%
• Triglycerides 100%
• Glycated Hemoglobin 66%
• Antidiabetic Drugs 66%
• Compliance Level 66%
• Metabolic 33%
• Endocrinologist 33%
• Hypertension 33%
• Antihypertensive Treatment 33%
• Anemia 33%
• Diabetic Patients 33%
• Insulin 33%
• Low-density Lipoprotein Cholesterol (LDL-C) 33%
• Creatinine 33%
• Proteinuria 33%
• Ophthalmic Examination 33%
• Consensus Document 33%
• Cardiovascular Events 33%
• Serum Creatinine 33%
• Blood Pressure Control 33%
• Cross-sectional Descriptive Study 33%
• Therapeutic Goals 33%
• Antiplatelet Treatment 33%
• Ambulatory BP Monitoring 33%
• Systolic Blood Pressure 33%
• High-density Lipoprotein Cholesterol (HDL-C) 33%
• Lipid Control 33%
• Therapeutic Measures 33%
• Waist Circumference 33%
• ANOVA Test 33%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 33%
• Angiotensin Receptor Blockers 33%
• Doctor-patient Relationship 33%
• Microalbuminuria 33%
• MDRD Equation 33%
• CKD Stage 33%
• Antiproteinuric Treatment 33%
• Nephroprotective 33%

Medicine and Dentistry

• Nephrology 100%
• Triacylglycerol 100%
• Diabetic Nephropathy 100%
• Creatinine 66%
• Hemoglobin A1c 66%
• Glycated Hemoglobin 66%
• Antidiabetic Agent 66%
• Diabetes Mellitus 33%
• Anemia 33%
• Blood Pressure 33%
• Systolic Blood Pressure 33%
• Proteinuria 33%
• Analysis of Variance 33%
• Antiplatelet 33%
• Cardiovascular System 33%
• Pressure Control 33%
• Endocrinologist 33%
• Post-Hoc Analysis 33%
• ACE Inhibitor 33%
• Angiotensin Receptor Antagonist 33%
• Microalbuminuria 33%
• Doctor Patient Relation 33%
• Renal Protection 33%
• Antihypertensive Therapy 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Triacylglycerol 100%
• Diabetic Nephropathy 100%
• Creatinine 66%
• Hemoglobin A1c 66%
• Antidiabetic Agent 66%
• Glycosylated Hemoglobin 66%
• Antiplatelet 33%
• Diabetes Mellitus 33%
• Antihypertensive Agent 33%
• Proteinuria 33%
• Anemia 33%
• Dipeptidyl Carboxypeptidase Inhibitor 33%
• Angiotensin Receptor Antagonist 33%
• Microalbuminuria 33%